Epoxyquinomicin B

Epoxyquinomicin B

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category Antibiotics
Catalog number BBF-00857
CAS 175448-32-5
Molecular Weight 289.24
Molecular Formula C14H11NO6

Online Inquiry

Description

Epoxyquinomicin B is an antibiotic produced by Amycolatopsis sp. MK299-95F4. It has moderate antibacterial activity against Pasteurella. It has a strong inhibitory effect on arthritis induced by oral collagen and is cytotoxic to several tumor cells.

Specification

Synonyms (1S)-2-Hydroxy-N-(6-(hydroxymethyl)-2,5-dioxo-7-oxabicyclo(4.1.0)hept-3-en-3-yl)benzamide; Benzamide, 2-hydroxy-N-(6-(hydroxymethyl)-2,5-dioxo-7-oxabicyclo(4.1.0)hept-3-en-3-yl)-, (1S)-
IUPAC Name 2-hydroxy-N-[(1S,6R)-6-(hydroxymethyl)-2,5-dioxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzamide
Canonical SMILES C1=CC=C(C(=C1)C(=O)NC2=CC(=O)C3(C(C2=O)O3)CO)O
InChI InChI=1S/C14H11NO6/c16-6-14-10(18)5-8(11(19)12(14)21-14)15-13(20)7-3-1-2-4-9(7)17/h1-5,12,16-17H,6H2,(H,15,20)/t12-,14+/m1/s1
InChI Key VIGCRVLJRHAWJR-OCCSQVGLSA-N

Properties

Appearance Light Yellow Powder
Antibiotic Activity Spectrum Gram-positive bacteria
Boiling Point 625.7°C at 760 mmHg
Melting Point 178-184°C
Density 1.63 g/cm3

Reference Reading

1. Epoxyquinomicins A, B, C and D, new antibiotics from Amycolatopsis. II. Effect on type II collagen-induced arthritis in mice
N Matsumoto, H Iinuma, T Sawa, T Takeuchi, S Hirano, T Yoshioka, M Ishizuka J Antibiot (Tokyo). 1997 Nov;50(11):906-11. doi: 10.7164/antibiotics.50.906.
The anti-arthritic effects of epoxyquinomicins on type II collagen-induced arthritis in DBA/1J mice were examined. Prophylactic treatment with epoxyquinomicins A, B, C and D (1-4 mg/kg) had potent inhibitory effects on type II collagen-induced arthritis. In contrast to nonsteroidal anti-inflammatory drugs (NSAIDs), epoxyquinomicin C (1-30 mg/kg) had neither an anti-inflammatory effect on carrageenan-induced paw edema in rats nor an analgesic effect on acetic acid-induced writhing in mice. These results suggest that the mode of action of epoxyquinomicins is different from that of NSAIDs and that epoxyquinomicins may become useful drugs for the treatment of rheumatoid arthritis.
2. Epoxyquinomicins A, B, C and D, new antibiotics from Amycolatopsis. III. Physico-chemical properties and structure determination
N Matsumoto, T Tsuchida, R Sawa, H Iinuma, H Nakamura, H Naganawa, T Sawa, T Takeuchi J Antibiot (Tokyo). 1997 Nov;50(11):912-5. doi: 10.7164/antibiotics.50.912.
The structures of epoxyquinomicins A (1), B (2), C (3) and D (4) were determined by spectroscopic studies. Compound 1 was determined to be (5R,6S)-2-(3-chloro-2-hydroxybenzoylamino)-5-hydroxymethyl-5,6-epo xy- 2-cyclohexene-1,4-dione. Compound 2 was revealed to be the dechlorinated derivative of 1. Compounds 3 and 4 were determined to be the reduced derivative of 2 and 1, respectively.
3. Synthesis of anti-rheumatic agent epoxyquinomicin B
N Matsumoto, H Iinuma, T Sawa, T Takeuchi Bioorg Med Chem Lett. 1998 Nov 3;8(21):2945-8. doi: 10.1016/S0960-894X(98)00529-0.
Anti-rheumatic agent (+/-)-epoxyquinomicin B was synthesized for a 22% overall yield in eight steps from commercially available 3-hydroxy-4-nitrobenzaldehyde via the intermediate quinone 6 prepared by selective phenol oxidation of 5 by use of Fremy's salt as the key step.

Recommended Products

BBF-01826 Deoxymannojirimycin Inquiry
BBF-02642 Lactonamycin Inquiry
BBF-03753 Baicalin Inquiry
BBF-01825 Loganin Inquiry
BBF-05862 Epirubicin Inquiry
BBF-02614 Nystatin Inquiry

Bio Calculators

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Recently viewed products

Online Inquiry

Verification code
cartIcon
Inquiry Basket